Introduction
It is well known that bacterial resistance to /Mactam antibiotics is primarily due to production of /Mactamase enzymes which hydrolyze the /Mactam ring, converting it into an inactive derivative. One approach to the problem of /Mactamase mediated resistance has been the development of /Mactamase inhibitors which, in combination with /Mactam antibiotics, provides a broad spectrum of activity against /Mactamase producing organisms. Clavulanate is a potent inhibitor of many /Mactamases; it functions as a suicide inhibitor, producing essentially irreversible inhibition of its /Mactamase targets (Reading & Cole, 1977) . Clinical experience has shown that the efficacy of antibiotic therapy depends not only on the direct effect exerted by the antibiotic on a given microorganism (expressed in terms of the minimum inhibitory or minimum bactericidal concentration) but also on the functional activity of the immune system of the host. There is evidence suggesting that many antimicrobial drugs can modulate host defences in various ways (Van den Broek, 1989; Carlone et al., 1991; Cuffini et al., 1993a; Gemmel, 1993; Labro, 1993; Carlone et al., 1994) . It thus follows that a possible influence (both negative and positive) of antibiotics on phagocyte functions should always be tested, especially when antibiotics are given for the treatment or prophylaxis of infections in immunocompromised patients, where it would be logical to employ drugs enhancing rather than depressing host defences.
The aim of this study was to compare the effects of amoxycillin and ticarcillin, both alone and in combination with clavulanic acid, upon the activities of human polymorphonuclear phagocytes towards Klebsiella pneumoniae. This Gram-negative human pathogen can pose severe problems in patients whose immunity is impaired by disease, trauma, or immunosuppressive drugs, since the majority of Klebsiella isolates possess a well-defined capsule which plays an important role in conferring resistance to host defences such as phagocytic cells (Williams, 1987) .
Materials and methods

Bacteria
A clinical strain of K. pneumoniae isolated from a patient with symptomatic urinary tract infection was cultured to mid-exponential phase in Brain Heart Infusion broth (BHI; Oxoid, Basingstoke, UK), concentrated ten times in BHI broth containing 30% glycerol, quick frozen in dry ice-ethanol and stored at -70°C.
Antibiotics
Disodium ticarcillin, amoxycillin trihydrate and lithium clavulanate were kindly provided by SmithKline Beecham, Milan, Italy. The compounds were dissolved in phosphate buffered saline (PBS; 0.1 M, pH 7.4) immediately before each experiment. Antibiotic susceptibility testing was performed by the standardized dilution method in Mueller-Hinton broth (Oxoid) with an inoculum of 2 x 10 7 cfu/mL. The combinations of ticarcillin/clavulanate and amoxycillin/clavulanate were tested as 7.5/1 and 2/1 ratio respectively.
Serum
Serum from a pool of healthy volunteers was used. After the blood had been allowed to clot for 1 h at room temperature, the serum was collected by centrifugation for 20 min at 1100 g, and stored in aliquots of 1 mL at -70°C until use. Human pooled serum (HPS) was used unheated providing an intact complement system.
Polymorphonuclear granulocytes (PMNs)
Peripheral venous blood from a pool of healthy volunteers was collected into sterile evacuated blood collecting tubes containing lithium heparin (15 units LH/mL blood) and settled at room temperature by gravity for 30 min in 2.5% dextran (70,000 mol wt; Pharmacia S.p.A., Milan, Italy) in normal saline (1:1 ratio). The leukocyte-rich plasma supernatant was carefully layered on Ficoll-Paque (Pharmacia) and then centrifuged twice at 160 g for 15 min; to obtain pure PMNs, residual erythrocytes were lysed by hypotonic shock for 30 seconds in sterile distilled water and then PMNs were further centrifuged. After being counted in a Biirker cell counting chamber, the PMNs density was adjusted to 10 6 cells/mL in PBS supplied with 1 % glucose and 0.1 % human albumin (Sigma); the PMNs were placed in plastic culture dishes (30 by 8 mm; Nunc, Copenhagen, Denmark), treated with RPMI 1640 (Gibco Laboratories, Grand Island, NY, USA), supplemented with 10% fetal calf serum (FCS; Gibco) and incubated for 15 min at 37 C C in 5% CO 2 . The non-adherent cells were discarded by rinsing with at Pennsylvania State University on February 23, 2013 http://jac.oxfordjournals.org/ Downloaded from phosphate-buffered saline and fresh RPMI 1640 was added to the monolayers. The viability was assayed by trypan blue exclusion and was greater than 95%; a viability test was done before and after each experiment. The time between collection of blood and the beginning of the experiments did not exceed 3 h; the interval between PMN harvest and the start of experiments was less than 30 min.
Opsonization procedure
Klebsiellae (5 x 10 7 cfu/mL) were incubated for different incubation times (15-30-60 min) at 37°C with 10% of HPS; opsonization was stopped by the addition of 2.5 mL of ice-cold phosphate saline, and serum was removed by centrifugation at 2000 g for 10 min; the bacteria were then resuspended in fresh medium to a final concentration of 2 x 10 7 cfu/mL, as confirmed by colony counts in triplicate.
Radioactive labelling protocol
Experiments were initiated by transferring 200 ^L of the frozen culture into fresh BHI broth containing 150/^Ci of 3 H-uracil (specific activity: 25 /iCi/mmol; Du Pont de Nemours, NEN Products, Milan, Italy). Following 4 h growth at 37°C, the radiolabelled klebsiellae were centrifuged several times with BHI broth and resuspended in fresh medium to a final concentration of 2 x 10 7 cfu/mL, as confirmed by colony counts in triplicate.
Phagocytosis assay
Aliquots of 1.0 mL of serum opsonized or non-opsonized klebsiellae in RPMI 1640 with 10% FCS, were added to PMN monolayers (10 6 cells/dish) and then incubated on a rocking platform at 37°C in 5% CO 2 in moist air. After incubation for periods varying from 30 to 90 min the plates were washed with phosphate saline to remove free klebsiellae and were resuspended in 1 mL of sterile distilled water for 5 min; 100//L samples of this suspension were placed in scintillation fluid (Atomlight, NEN) and counted by liquid scintillation spectrometry. Radioactivity was expressed as cpm/sample. The percentage of phagocytosis at a given sampling time (Carlone et al., 1989) was calculated as:
Measurement of antimicrobial activity of PMNs
Aliquots of 1 mL of klebsiellae (2 x 10 7 cfu) and PMNs (10* cells/dish) were incubated for 30 min in RPMI 1640 medium to allow phagocytosis to proceed. The PMN monolayers were washed vigorously several times with phosphate saline to remove free extracellular bacteria. Samples of the cells containing bacteria were lysed by adding sterile water and a viable count of intracellular klebsiellae was performed (T o ). The cells were then incubated further and at intervals (T.) viable counts of surviving intracellular bacteria were measured in the same way. The PMN killing values were expressed as a Survival Index (SI), calculated as the number of surviving microorganisms at 30 min
(T a ) plus the number of surviving microorganisms at T t over the number of surviving microorganisms at 30 min (T o ), by the following formula (Cuffini et al., 19936): _ no. of cfu at T o + no. of cfu at T, no. of cfu at T o According to this formula, if 100% killing took place, the ratio would be 1.
Effect of antibiotics on PMN functions
The effects of the two /Mactams, both alone and in combination with clavulanic acid, on PMN phagocytosis and intracellular killing towards non-opsonized or opsonized K. pneumoniae were investigated by incubating the bacteria and phagocyte monolayers at 37°C in the presence of 0.5 x MIC of the drugs.
To differentiate any separate effect of drugs on bacteria and phagocytes, experiments were conducted following exposure of phagocytes to the antibiotics before they were incubated with klebsiellae. The PMN monolayers were pre-incubated at 37°C in 5% CO 2 in moist air for 1 h with 1.0 mL of drugs (1/2 MIC) or 1.0 mL of sterile balanced salt solution as control group. After several washings with phosphate saline to remove the antibiotic, 1.0 mL of fresh RPMI medium with 10% FCS containing klebsiellae at 2 x 10 7 cfu was added to PMNs for the assays.
Statistical analysis
Every test was carried out in quadruplicate and compared with control systems which contained no antibiotics. Results are expressed as the mean and standard error of ten separate experiments. Statistical evaluation of the differences between test and control results were performed by an analysis of variance (ANOVA) by Tukey's test.
Transmission electron microscopy
Colonies of K. pneumoniae were cultured in BH1 broth (2 x 10 7 cfu/mL) containing 0.5 x MIC of antibiotic (ticarcillin, or amoxycillin, or their combinations with clavulanic acid). Controls without drugs were set up. After 1 h incubation the antibiotics were removed by centrifugation at 2000 g for 10 min; the supernatant was replaced with 1.0 mL of 2.5% glutaraldehyde in phosphate buffer at pH 7.3 and fixed for 1 h at room temperature. Pellets were postfixed in 2% osmium tetroxide for 20 min and dehydrated through graded ethanol solutions and propylene oxide and they were then embedded in ACM Durcupam (Fluka, Switzerland) (Carlone, Cuffini & Cattaneo, 1982) . The specimens were cut with a Sorvall MT 2 ultramicrotome and examined with a Philips EM 300 electron microscope.
Results
MIC determination
The MICs of both ticarcillin and amoxycillin for /Mactamase producing strain of K. pneumoniae (2 x 10 7 cfu/mL) were higher than 128 mg/L. The activity of ticarcillin and amoxycillin against this strain was enhanced (32 and 16 mg/L) in the presence of clavulanic acid, as a result of the /Mactamase inhibitory properties of clavulanic acid. 
Effects of drugs on PMN phagocytosis
In all the experiments the viability of PMNs remained unchanged throughout. The presence of 0.5 x MIC of ticarcillin, ticarcillin/clavulanic acid and amoxycillin similarly affected the rate of human granulocyte phagocytosis, resulting in an increased percentage of ingested klebsiellae over all three timepoints, in comparison with the control (P<0.0\; Table I ). A somewhat different result was seen in presence of amoxycillin/clavulanic acid: the uptake was significantly, always markedly increased (18-23% phagocytosis) when compared with the other systems (/ > <0.01; Table I ).
In the absence of the drugs, serum pre-opsonization of the klebsiellae (Table II) resulted only in a slightly more efficient phagocytosis by PMNs, in comparison with that observed with non-opsonized bacteria. To find out a possible difference in uptake, experiments were also performed with longer opsonization times (30-60 min), but we failed to show such a difference. In presence of ticarcillin and ticarcillin/clavulanic acid (0.5 x MIC) the uptake of opsonized klebsiellae was enhanced to about the same extent as that seen with non-serum-treated bacteria; on the other hand, the presence of both amoxycillin and amoxycillin/clavulanic acid led to a significantly greater phagocytosis of opsonized K. pneumoniae, in comparison with either the control or the other drug-systems (P < 0.01; Table II ). The pre-exposure of phagocytes to 0.5 x MIC of drugs for 1 h had no effect on the phagocytosis of K. pneumoniae.
Effects of drugs on PMNs intracellular killing
The incubation of PMNs containing intracellular klebsiellae in an antibiotic-free control culture resulted in an increase in viable counts: Sis were >2, which is compatible with intracellular survival (Table III) . •Significantly different (P < 0.01) from the controls. Ticarcillin and more markedly amoxycillin, added to PMNs after the phagocytosis had occurred, significantly enhanced phagocyte intracellular microbicidal activity against ingested resistant klebsiellae. During the 90 min period the number of intracellular bacteria fell by 54% and 85% respectively. Both ticarcillin/clavulanic acid and amoxycillin/clavulanic acid were more effective than ticarcillin or amoxycillin alone in reducing the number of viable intracellular klebsiellae, leading to a 100% of killing (/><0.01; Table III) .
Serum-opsonized bacteria, once phagocytosed, remained as viable in the phagocytes as untreated bacteria (Table IV) . The addition of 0.5 x MIC of ticarcillin and amoxycillin to PMNs, after the phagocytosis had occurred, resulted in the opsonized K. pneumoniae being more readily killed than were non-opsonized bacteria (at 90 min 90-99% vs 54-85%). Again, the presence of both /?-lactams combined with clavulanic acid resulted in a total bacterial killing in the intracellular compartment (P < 0.01; Table IV ).
Discussion
Amoxycillin is a semisynthetic hydroxy-derivative of ampicillin, active against both Gram-positive and Gram-negative bacteria, but its bactericidal activity and intestinal absorption is greater than that of ampicillin and its tissue diffusion is more extensive (Giachino et al., 1993) . Ticarcillin, which is a parenteral antibiotic, has a similar broad spectrum of action to ampicillin and amoxycillin and is also active against Pseudomonas aeruginosa. The increasingly high prevalence of /Mactamase producing strains is diminishing the utility of many /Mactams for the treatment of most bacterial infections. The use of /Mactam antibiotics in combination with suicide inhibitors, such as clavulanic acid, sulbactam and tazobactam may allow greater potentiation of the labile-antibiotics against /Mactamase producing strains and therefore may have an increasing role in the therapy of infections substained by these microorganisms. The combination of both amoxycillin and ticarcillin with clavulanic acid has been shown to extend their spectrum to include /Mactamase producing strains both in vitro (White et al., 1985; Giachino et al., 1993) and in vivo and successful treatment of severe clinical bacterial infections with these combinations has been reported (Cooper, Slocombe & White, 1990; Beale et al., 1991; Catherall et al., 1992) . This investigation delineates and compares the effects of ticarcillin and amoxycillin with that of their combination with clavulanic acid upon the human granulocyte functions, mainly phogocytosis and killing, against a /Mactamase producing strain of K. pneumoniae.
Many investigations of the effects of antimicrobial agents on host defence mechanisms have shown that antibiotics can act in different ways (van den Broek, 1989; Miler et al., 1990; Labro, El Benna & Abdelghaffar, 1993; Carlone et al., 1994) . When bacteria, phagocytes and antibiotics are all present together, general absence of phagocyte function, impairment and synergism with phagocytes has been shown for most 0-lactam antibiotics Cuffini et al., 1993a; Gemmel, 1993) . Our data show that ticarcillin, at 0.5 x MIC, was able to enhance either the bacterial uptake (Table I) or the intracellular killing (Table III) of resistant K. pneumoniae by human PMNs, over all three timepoints. In presence of 0.5 x MIC of amoxycillin, a pattern of phagocytosis similar to that seen with ticarcillin was detected (Table I) , whereas a superior microbicidal activity on intracellular klebsiellae was observed (71-85% vs 47-54%, Table III) .
We speculate that the enhancement that we observed is probably related to the direct ticarcillin or amoxycillin-induced changes in cell wall integrity so that the phagocytes may react towards klebsiellae in a more positive manner. In fact, there is fairly consistent evidence that antibiotics acting on the cell wall do not directly affect phagocyte functions, but indirectly may alter bacterial susceptibility to phagocytosis and killing, interfering with some cellular mechanisms necessary for the maintenance of the surface integrity of the bacterium, without affecting viability (Carlone et al., , 1994 . Our ultrastructural observations (data not shown) corroborate these observations: in fact, both /Mactams act by binding primarily to PBP 3 of Gram-negative bacteria and hence exert a profound effect on K. pneumoniae ultrastructure morphology resulting in changes in cell surface, and irregular, aberrant cellular shape with disorganized cytoplasm (changes similar to those detectable in bacteria isolated from individuals under /J-lactam therapy) in ways that may alter bacterial susceptibilities to granulocyte phagocytosis and killing. However, with ampicillin, a structurally related penicillin, different results have been reported . Under the same experimental conditions, ampicillin, at half its MIC, was incapable of increasing the susceptibility of bacteria to both phagocytosis and killing , perhaps reflecting the differing morphological effects and less rapid bactericidal effects of ampicillin against Gram-negative bacteria (Rolinson, MacDonald & Wilson, 1977) .
Clavulanic acid alone did not have any significant effect upon the phagocytosis of PMNs and killing of intracellular klebsiellae. The presence of clavulanic acid, with its /?-lactamase inhibitory properties, may sensitize in a more positive manner the organisms to PMN attack. In fact, the suicide inhibitor potentiated the activity of both penicillins against the /Mactamase producing strain of K. pneumoniae, enhancing the antibiotics ability to alter the surface structures of bacteria, as indicated by microscopic investigation, so as to facilitate the phagocytosis (Table I) and greatly increase the susceptibility of the klebsiellae to microbicidal PMN systems (Table III) . The synergy observed between granulocytes and the drugs for bacterial phagocytosis and killing cannot be related to a direct stimulation of PMN functions. The direct 1 h pre-treatment of human PMNs with 0.5 x MIC of both ticarcillin and amoxycillin (either alone or in combination with clavulanic acid) did not have any effect upon phagocyte uptake and subsequent killing of intracellular klebsiellae: in fact, the results were similar to those seen with the untreated phagocytes (Tables I and III), confirming that the drugs do not directly interfere with the phagocyte activities; it is concluded that this synergy depends on alteration of the bacteria.
The bactericidal activity of serum and the phagocytic capacity of PMNs constitute important host defence mechanisms against invading bacteria. Many Gram-negative bacteria are sensitive to the killing capacity of serum; however our results show that, in the control systems, serum pre-opsonization of klebsiellae resulted in a PMN phagocytosis only slightly more efficient (Table II) in comparison with non-opsonized bacteria, but did not affect bacterial susceptibility to microbicidal systems (Table IV) . No significant differences in PMN uptake and bacterial killing were detectable with different opsonization times. In the presence of ticarcillin and ticarcillin/clavulanic acid the uptake of opsonized klebsiellae was enhanced to about the same as that observed with untreated bacteria (Table II) ; in contrast, both amoxycillin and amoxycillin/clavu-lanic acid produced a significantly greater enhancement of uptake of opsonized klebsiellae (Table II) ; this advantage seems to depend on amoxycillin being intrinsically more active than ticarcillin. Once phagocytosed, opsonized klebsiellae, were more easily killed by PMNs in presence of both penicillins (Table IV) than were serum untreated bacteria. Both ticarcillin/clavulanic acid and amoxycillin/clavulanic acid were more active in reducing the number of viable opsonized klebsiellae, leading to a complete elimination of microorganisms from the intracellular compartment (Table IV) , indicating a synergistic effect between drugs and serum activity.
In conclusion, the current results indicate that clavulanic acid, with its /Mactamase inhibitory properties, potentiated the efficacy of both ticarcillin and amoxycillin against a /?-lactamase producing strain of K. pneumoniae, either serum unopsonized or opsonized, resulting in a significant increased bacterial susceptibility to phagocytic and microbicidal activities of human PMNs. It emerges from these results that amoxycillin/clavulanic acid possesses interesting beneficial properties which result in enhancement of the microbicidal proterties of human PMNs and may make this combination more suitable for the treatment of infections in patients with defects of phagocytic function.
